Stock 4568 DAIICHI SANKYO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Delayed Japan Exchange
Other stock markets
 08:51:24 2024-04-29 pm EDT 		5-day change 1st Jan Change
5,328 JPY +6.35% Intraday chart for Daiichi Sankyo Co., Ltd. +13.98% +37.27%
Apr. 29 AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement MT
Apr. 29 AstraZeneca makes progress with Truqap and Enhertu cancer treatments AN

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
INTERVIEW - Hiroyuki Okuzawa, CEO of Daiichi Sankyo: Confident about the future thanks to the drug pipeline
MT
Daiichi Sankyo Company, Limited Announces Retirement of Noritaka Uji, Outside Director
CI
Daiichi Sankyo Posts 8% Decline in Fiscal Nine-month Attributable Profit on Growing Expenses; Rejigs Management Structure
MT
Daiichi Sankyo Company, Limited Appoints Hiroyuki Okuzawa as New President & COO Effective as of April 1, 2023
CI
Daiichi Sankyo Company, Limited Announces Executives Retirement, Effective as of June 21, 2021
CI
Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D with Effect from April 1, 2021
CI
Daiichi Sankyo Company, Limited Appoints New Corporate Officers, Effective April 1, 2021
CI
Daiichi Sankyo Company, Limited Announce Board Resignations
CI
Daiichi Sankyo Company, Limited Announces Changes to Members of the Board and Members of the Audit and Supervisory Board
CI
Daiichi Sankyo Company, Limited Announces Management Changes
CI
Daiichi Sankyo Company, Limited Announces the Management Changes
CI
Daiichi Sankyo Company, Limited Announces Executive Changes
CI
Daiichi Sankyo Company, Limited Announces New Group Corporate Officers Effective from April 1, 2019
CI
Daiichi Sankyo Company, Limited Appoints New Group Corporate Officers
CI
Daiichi Sankyo Company, Limited Announces Executive Changes
CI
Daiichi Sankyo, Inc. Appoints Leigh Ann Errico as Vice President of Human Resources for the U.S. Administrative and Commercial Group
CI
Daiichi Sankyo Company Limited Announces Management Changes
CI
Daiichi Sankyo Appoints Dr. Antoine Yver as Global Head, Oncology Research and Development
CI
Daiichi Sankyo Company, Limited Announces Appointment of New Group Corporate Officers, Effective April 1, 2016
CI
Daiichi Sankyo Company, Limited Announces Executive Appointments
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4568 Stock
  4. News Daiichi Sankyo Co., Ltd.
  5. Insiders